Highlights:,Merck & Co Inc's experimental treatment, clesrovimab, has demonstrated positive results in a mid- to late-stage ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

First flu-related death of 2024-2025 flu season reported in North Carolina. NCDHHS recommends vaccinations and protective ...

The respiratory syncytial virus (RSV) vaccines were about 80% effective in older adults during the 2023-24 respiratory disease season, which was the first season after the shot was approved in the US, ...

A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the ...

Pfizer's RSV vaccine was 90% effective at preventing the most severe outcomes in the first-ever vaccination season, the ...

Dairy workers in California continue to face a daunting threat from a virus surge in the state’s dairy cows, as federal ...

The N.C. Department of Health and Human Services is reporting the first flu-related death of the 2024-25 flu season. An adult in the Charlotte metropolitan area died due to complications ...

DHHS says that influenza, COVID-19 and respiratory syncytial virus (RSV) are expected to increase over the coming weeks.